Silencing of neurotropic flavivirus replication in the central nervous system by combining multiple microRNA target insertions in two distinct viral genome regions

Virology

Volumn 456-457, Issue 1, 2014, Pages 247-258

  Teterina, Natalya L ^a   Liu, Guangping ^a   Maximova, Olga A ^a   Pletnev, Alexander G ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Flavivirus; Micrornas; Neuropathogenesis

Indexed keywords

MICRORNA; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN DEVELOPMENT; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; FLAVIVIRUS; GENE EXPRESSION; GENE INSERTION; GENE SILENCING; GENE TARGETING; MOUSE; NEUROTROPISM; NEWBORN; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; RAT; VIRUS GENOME; VIRUS REPLICATION;

FLAVIVIRUS; MICRORNAS; NEUROPATHOGENESIS;

ANIMALS; ANIMALS, NEWBORN; BRAIN; DISEASE MODELS, ANIMAL; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; GENOME, VIRAL; MICE; MICRORNAS; MUTAGENESIS, INSERTIONAL; NEURONS; VIRAL TROPISM; VIRUS REPLICATION;

EID: 84898819743     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.04.001     Document Type: Article

References (46)

1. Barnes D., Kunitomi M., Vignuzzi M., Saksela K., Andino R. Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 2008, 4:239-248.
2. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
3. Bonaldo M.C., Mello S.M., Trindade G.F., Rangel A.A., Duarte A.S., Oliveira P.J., Freire M.S., Kubelka C.F., Galler R. Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes. Virol. J. 2007, 4:115.
4. Cawood R., Chen H.H., Carroll F., Bazan-Peregrino M., van Rooijen N., Seymour L.W. Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells. PLoS Pathog. 2009, 5:e1000440.
5. Cawood R., Wong S.L., Di Y., Baban D.F., Seymour L.W. MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity. PLoS One 2011, 6:e16152.
6. Edge R.E., Falls T.J., Brown C.W., Lichty B.D., Atkins H., Bell J.C. A let-7 microRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication. Mol. Ther. 2008, 16:1437-1443.
7. Engel A.R., Rum yantsev A.A., Maximova O.A., Speicher J.M., Heiss B., Murphy B.R., Pletnev A.G. The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genome. Virology 2010, 405:243-252.
8. Fang Z., Rajewsky N. The impact of miRNA target sites in coding sequences and in 3'UTRs. PLoS One 2011, 6:e18067.
9. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 2008, 9:102-114.
10. Fritz R., Blazevic J., Taucher C., Pangerl K., Heinz F.X., Stiasny K. The unique transmembrane hairpin of flavivirus fusion protein E is essential for membrane fusion. J. Virol. 2011, 85:4377-4385.
11. Griffin D.E. Immune responses to RNA-virus infections of the CNS. Nat. Rev. Immunol. 2003, 3:493-502.
12. Heiss B.L., Maximova O.A., Pletnev A.G. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype. J. Virol. 2011, 85:1464-1472.
13. Heiss B.L., Maximova O.A., Thach D.C., Speicher J.M., Pletnev A.G. MicroRNA targeting of neurotropic flavivirus: effective control of virus escape and reversion to neurovirulent phenotype. J. Virol. 2012, 86:5647-5659.
14. Kelly E.J., Hadac E.M., Cullen B.R., Russell S.J. MicroRNA antagonism of the picornaviral life cycle: alternative mechanisms of interference. PLoS Pathog. 2010, 6:e1000820.
15. Kelly E.J., Hadac E.M., Greiner S., Russell S.J. Engineering microRNA responsiveness to decrease virus pathogenicity. Nat. Med. 2008, 14:1278-1283.
16. Kelly E.J., Nace R., Barber G.N., Russell S.J. Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. J. Virol. 2010, 84:1550-1562.
17. Kelly E.J., Russell S.J. MicroRNAs and the regulation of vector tropism. Mol. Ther. 2009, 17:409-416.
18. Krichevsky A.M., King K.S., Donahue C.P., Khrapko K., Kosik K.S. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 2003, 9:1274-1281.
19. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 2002, 12:735-739.
20. Langlois R.A., Albrecht R.A., Kimble B., Sutton T., Shapiro J.S., Finch C., Angel M., Chua M.A., Gonzalez-Reiche A.S., Xu K., Perez D., Garcia-Sastre A., Tenoever B.R. MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies. Nat. Biotechnol. 2013, 9:844-847.
21. Langlois R.A., Varble A., Chua M.A., Garcia-Sastre A., tenOever B.R. Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:12117-12122.
22. Lauring A.S., Jones J.O., Andino R. Rationalizing the development of live attenuated virus vaccines. Nat. Biotechnol. 2010, 28:573-579.
23. Leber M.F., Bossow S., Leonard V.H., Zaoui K., Grossardt C., Frenzke M., Miest T., Sawall S., Cattaneo R., von Kalle C., Ungerechts G. MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism. Mol. Ther. 2011, 19:1097-1106.
24. Lin H.R., Ganem D. Viral microRNA target allows insight into the role of translation in governing microRNA target accessibility. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5148-5153.
25. Lindenbach B., Thiel H., Rice C.M. Flaviviridae: the viruses and their replication. Fields Virology 2007, 1101-1152. Lippincott, Williams & Wilkins, Philadelphia, PA. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
26. Mandl C.W. Steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis. Virus Res. 2005, 111:161-174.
27. Mrass P., Weninger W. Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors. Immunol. Rev. 2006, 213:195-212.
28. Ousman S.S., Kubes P. Immune surveillance in the central nervous system. Nat. Neurosci. 2012, 15:1096-1101.
29. Pangerl K., Heinz F.X., Stiasny K. Mutational analysis of the zippering reaction during flavivirus membrane fusion. J. Virol. 2011, 85:8495-8501.
30. Pasquinelli A.E. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat. Rev. Genet. 2012, 13:271-282.
31. Perez J.T., Pham A.M., Lorini M.H., Chua M.A., Steel J., tenOever B.R. MicroRNA-mediated species-specific attenuation of influenza A virus. Nat. Biotechnol. 2009, 27:572-576.
32. Pham A.M., Langlois R.A., TenOever B.R. Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS Pathog. 2012, 8:e1002465.
33. Pletnev A.G. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice. Virology 2001, 282:288-300.
34. Pletnev A.G., Bray M., Hanley K.A., Speicher J., Elkins R. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes. J. Virol. 2001, 75:8259-8267.
35. Pletnev A.G., Bray M., Huggins J., Lai C.J. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:10532-10536.
36. Pletnev A.G., Swayne D.E., Speicher J., Rumyantsev A.A., Murphy B.R. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity. Vaccine 2006, 24:6392-6404.
37. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoint. Am. J. Epidemiol. 1938, 27:493-497.
38. Rumyantsev A.A., Chanock R.M., Murphy B.R., Pletnev A.G. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys. Vaccine 2006, 24:133-143.
39. Saetrom P., Heale B.S., Snove O., Aagaard L., Alluin J., Rossi J.J. Distance constraints between microRNA target sites dictate efficacy and cooperativity. Nucleic Acids Res. 2007, 35:2333-2342.
40. Sips G.J., Wilschut J., Smit J.M. Neuroinvasive flavivirus infections. Rev. Med. Virol. 2012, 22:69-87.
41. Stiasny K., Kiermayr S., Bernhart A., Heinz F.X. The membrane-proximal "stem" region increases the stability of the flavivirus e protein postfusion trimer and modulates its structure. J. Virol. 2013, 87:9933-9938.
42. tenOever B.R. RNA viruses and the host microRNA machinery. Nat. Rev. Microbiol. 2013, 11:169-180.
43. Trindade G.F., de Santana M.G., dos Santos J.R., Galler R., Bonaldo M.C. Retention of a recombinant GFP protein expressed by the yellow fever 17D virus in the E/NS1 intergenic region in the endoplasmic reticulum. Mem. Inst. Oswaldo Cruz 2012, 107:262-272.
44. Yen L.C., Lin Y.L., Sung H.H., Liao J.T., Tsao C.H., Su C.M., Lin C.K., Liao C.L. Neurovirulent flavivirus can be attenuated in mice by incorporation of neuron-specific microRNA recognition elements into viral genome. Vaccine 2013, 31:5915-5922.
45. Ylosmaki E., Hakkarainen T., Hemminki A., Visakorpi T., Andino R., Saksela K. Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific microRNA. J. Virol. 2008, 82:11009-11015.
46. Ylosmaki E., Martikainen M., Hinkkanen A., Saksela K. Attenuation of Semliki Forest virus neurovirulence by microRNA-mediated detargeting. J. Virol. 2013, 87:335-344.